Clinical Attestation and Redox Mechanism of Ascorbic Acid in the Treatment of Cancer


  • Sanjib Bhattacharya West Bengal Medical Services Corporation Ltd., GN 29, Sector V, Salt Lake, Kolkata, West Bengal, INDIA.



Ascorbic acid, Reactive oxygen species (ROS), Intravenous, Angiogenesis, Clinical


Ascorbic acid (Vitamin C) is an essential micro-nutrient, an outstanding antioxidant and an essential co-factor in different mammalian enzymatic processes. There is considerable clinical attestation that, high dose of intravenous ascorbic acid can improve cancer patients with or without extant therapeutic involvements. Ascorbic acid in high intravenous doses serves as pro-oxidant and promotes the generation of hydrogen peroxide (H2O2) and other reactive oxygen species (ROS) with oxidative stress-induced toxicity selectively to cancer cells. This effect also hampers the bioenergetics and angiogenesis of malignant cells, resulting in cancer cell death. Large doses of ascorbic acid are safe and well-tolerated. On account of its antioxidant effect, ascorbic acid supplementation may be applied as an adjuvant with regular cancer therapy to minimize complications. Nevertheless, there is a necessity for further mechanistic studies and randomized controlled clinical trials to evaluate the benefit of ascorbic acid in the treatment of cancer.


Download data is not yet available.


Metrics Loading ...
Oxidation of ascorbic acid.



DOI: 10.5530/fra.2021.1.1
Published: 2021-07-30

How to Cite

Bhattacharya, S. (2021). Clinical Attestation and Redox Mechanism of Ascorbic Acid in the Treatment of Cancer. Free Radicals and Antioxidants, 11(1), 1–6.

Most read articles by the same author(s)